Crinetics Pharmaceuticals, Inc. (CRNX) has 21 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $120K. Most recent filing: Sept. 1, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 1, 2026 | WIERENGA WENDELL Director | $16,879,754 | 232,151 | −100% | No | |
|
|
||||||
| Sept. 1, 2026 | Okey Stephanie Director | $7,133,169 | 117,405 | −100% | No | |
|
|
||||||
| Sept. 1, 2026 | Vivaldi Coelho Rogerio Director | $6,860,682 | 113,055 | −100% | No | |
|
|
||||||
| Sept. 1, 2026 | Fust Matthew K Director | $5,277,204 | 80,933 | −100% | No | |
|
|
||||||
| Sept. 1, 2026 | Bedrosian Camille L Director | $8,571,719 | 132,305 | −100% | No | |
|
|
||||||
Showing the 5 most recent of 21 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free